ペニシリン市場は2023年から2028年に28億2,000万米ドル、予測期間中のCAGRは5.4％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、感染症の有病率の上昇、様々な疾患とその治療に対する意識の高まり、ペニシリンの品質を促進する特別な規制指定によって牽引されています。
本調査では、ペニシリンベンダー間の戦略的提携やM&Aが、今後数年間のペニシリン市場成長を牽引する主要因の1つであると分析しています。また、抗生物質研究への資金提供の増加や輸血による感染拡大のリスクの高まりも、市場の大きな需要につながると思われます。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global penicillin market 2018 - 2022
4.2 Source Segment Analysis 2018 - 2022
4.3 Type Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Source
6.1 Market segments
6.2 Comparison by Source
6.3 Semisynthetic - Market size and forecast 2023-2028
6.4 Natural - Market size and forecast 2023-2028
6.5 Market opportunity by Source
7 Market Segmentation by Type
7.1 Market segments
7.2 Comparison by Type
7.3 Oral - Market size and forecast 2023-2028
7.4 Parenteral - Market size and forecast 2023-2028
7.5 Market opportunity by Type
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 UK - Market size and forecast 2023-2028
9.9 China - Market size and forecast 2023-2028
9.10 Germany - Market size and forecast 2023-2028
9.11 Canada - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Abbott Laboratories
12.4 AdvaCare Pharma
12.5 Aenova Holding GmbH
12.6 Canvax Biotech SL
12.7 Cipla Ltd.
12.8 F. Hoffmann La Roche Ltd.
12.9 GlaxoSmithKline Plc
12.10 Glenmark Pharmaceuticals Ltd.
12.11 Lupin Ltd.
12.12 Merck KGaA
12.13 Novartis AG
12.14 Pfizer Inc.
12.15 Recipharm AB
12.16 Sanofi SA
12.17 Viatris Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Source
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global penicillin market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Source Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Source - Market share 2023-2028 (%)
Exhibits31: Data Table on Source - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Source
Exhibits33: Data Table on Comparison by Source
Exhibits34: Chart on Semisynthetic - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Semisynthetic - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Semisynthetic - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Semisynthetic - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Natural - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Natural - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Natural - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Natural - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Source ($ billion)
Exhibits43: Data Table on Market opportunity by Source ($ billion)
Exhibits44: Chart on Type - Market share 2023-2028 (%)
Exhibits45: Data Table on Type - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Type ($ billion)
Exhibits57: Data Table on Market opportunity by Type ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories - Overview
Exhibits108: Abbott Laboratories - Business segments
Exhibits109: Abbott Laboratories - Key news
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: AdvaCare Pharma - Overview
Exhibits113: AdvaCare Pharma - Product / Service
Exhibits114: AdvaCare Pharma - Key offerings
Exhibits115: Aenova Holding GmbH - Overview
Exhibits116: Aenova Holding GmbH - Product / Service
Exhibits117: Aenova Holding GmbH - Key offerings
Exhibits118: Canvax Biotech SL - Overview
Exhibits119: Canvax Biotech SL - Product / Service
Exhibits120: Canvax Biotech SL - Key offerings
Exhibits121: Cipla Ltd. - Overview
Exhibits122: Cipla Ltd. - Business segments
Exhibits123: Cipla Ltd. - Key news
Exhibits124: Cipla Ltd. - Key offerings
Exhibits125: Cipla Ltd. - Segment focus
Exhibits126: F. Hoffmann La Roche Ltd. - Overview
Exhibits127: F. Hoffmann La Roche Ltd. - Business segments
Exhibits128: F. Hoffmann La Roche Ltd. - Key news
Exhibits129: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits130: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits131: GlaxoSmithKline Plc - Overview
Exhibits132: GlaxoSmithKline Plc - Business segments
Exhibits133: GlaxoSmithKline Plc - Key news
Exhibits134: GlaxoSmithKline Plc - Key offerings
Exhibits135: GlaxoSmithKline Plc - Segment focus
Exhibits136: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits137: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits138: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits139: Lupin Ltd. - Overview
Exhibits140: Lupin Ltd. - Product / Service
Exhibits141: Lupin Ltd. - Key news
Exhibits142: Lupin Ltd. - Key offerings
Exhibits143: Merck KGaA - Overview
Exhibits144: Merck KGaA - Business segments
Exhibits145: Merck KGaA - Key news
Exhibits146: Merck KGaA - Key offerings
Exhibits147: Merck KGaA - Segment focus
Exhibits148: Novartis AG - Overview
Exhibits149: Novartis AG - Business segments
Exhibits150: Novartis AG - Key offerings
Exhibits151: Novartis AG - Segment focus
Exhibits152: Pfizer Inc. - Overview
Exhibits153: Pfizer Inc. - Product / Service
Exhibits154: Pfizer Inc. - Key news
Exhibits155: Pfizer Inc. - Key offerings
Exhibits156: Recipharm AB - Overview
Exhibits157: Recipharm AB - Business segments
Exhibits158: Recipharm AB - Key offerings
Exhibits159: Recipharm AB - Segment focus
Exhibits160: Sanofi SA - Overview
Exhibits161: Sanofi SA - Business segments
Exhibits162: Sanofi SA - Key news
Exhibits163: Sanofi SA - Key offerings
Exhibits164: Sanofi SA - Segment focus
Exhibits165: Viatris Inc. - Overview
Exhibits166: Viatris Inc. - Business segments
Exhibits167: Viatris Inc. - Key news
Exhibits168: Viatris Inc. - Key offerings
Exhibits169: Viatris Inc. - Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations
